Switch to:
More From Other Websites
REPROS THERAPEUTICS INC. Files SEC form 8-K, Regulation FD Disclosure Aug 18 2016
REPROS THERAPEUTICS INC. Financials Aug 17 2016
Repros Presents 6-Month Interim Data on Enclomiphene Aug 16 2016
Repros Provides Six Month Interim Results for Enclomiphene Study in Obese Secondary Hypogonadal Men Aug 15 2016
REPROS THERAPEUTICS INC. Files SEC form 8-K, Other Events Aug 15 2016
Repros Provides Six Month Interim Results for Enclomiphene Study in Obese Secondary Hypogonadal Men Aug 15 2016
Repros (RPRX) Q2 Loss Narrower Y/Y, Focus on Pipeline Aug 10 2016
REPROS THERAPEUTICS INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Aug 09 2016
Repros Therapeutics Inc.® Reports Second Quarter 2016 Financial Results Aug 09 2016
Repros Therapeutics reports 2Q loss Aug 09 2016
Repros Therapeutics reports 2Q loss Aug 09 2016
Repros Therapeutics Inc.® Reports Second Quarter 2016 Financial Results Aug 09 2016
Repros (RPRX) Q2 Earnings: What's in Store for the Stock? Aug 04 2016
8 Stocks Under $10 to Trade for Huge Profits Jul 29 2016
REPROS THERAPEUTICS INC. Files SEC form 8-K, Regulation FD Disclosure Jul 19 2016
5 Top Biotech Performers of 2016 Jul 01 2016
REPROS THERAPEUTICS INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Jul 01 2016
Research Report Initiated on Select Biotechnology Equities Jun 24 2016
REPROS THERAPEUTICS INC. Files SEC form 8-K, Regulation FD Disclosure Jun 07 2016
6 Biotechs Seriously on the Move Jun 02 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK